1. Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin’s lymphoma
   Ahmed M. L. Bedewy et al, 2013, Annals of Hematology CrossRef
2. The role of the DFF40/CAD endonuclease in genomic stability
   Merve Kulbay et al, 2021, Apoptosis CrossRef
3. Subgrouping breast cancer patients based on immune evasion mechanisms unravels a high involvement of transforming growth factor-beta and decoy receptor 3
   Mayassa J. Bou-Dargham et al, 2018, PLOS ONE CrossRef
4. Knockdown of Decoy Receptor 3 Impairs Growth and Invasiveness of Hepatocellular Carcinoma Cell Line of HepG2
   Xiao-Na Zhou et al, 2016, Chinese Medical Journal CrossRef
5. Absolute quantification of DcR3 and GDF15 from human serum by LC‐ESI MS
   Ioana Lancrajan et al, 2015, Journal of Cellular and Molecular Medicine CrossRef
6. Senescent cells: an emerging target for diseases of ageing
   Bennett G. Childs et al, 2017, Nature Reviews Drug Discovery CrossRef
7. Expression and function of vascular endothelial growth inhibitor in aged porcine bladder detrusor muscle cells
   Mingqing Wang et al, 2013, Biogerontology CrossRef
8. Decoy receptor 3 suppresses FasL-induced apoptosis via ERK1/2 activation in pancreatic cancer cells
   Yi Zhang et al, 2015, Biochemical and Biophysical Research Communications CrossRef
9. Apoptosis-Inducing TNF Superfamily Ligands for Cancer Therapy
   Olivia A. Diaz Arguello et al, 2021, Cancers CrossRef
10. The siRNA silencing of DcR3 expression induces Fas ligand-mediated apoptosis in HepG2 cells
    Tuanjie Zhao et al, 2018, Experimental and Therapeutic Medicine CrossRef
11. Esophageal cancer cells convert the death signal from TRAIL into a stimulus for survival during acid/bile exposure
    Zhiheng Chang et al, 2020, Digestive and Liver Disease CrossRef
12. Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3
    Nicolas Porquet et al, 2011, BMC Cancer CrossRef
13. Systemic and local expression levels of TNF‐like ligand 1A and its decoy receptor 3 are increased in primary biliary cirrhosis
    Yoshihiro Aiba et al, 2014, Liver International CrossRef
14. Sodium valproate, a histone deacetylase inhibitor, modulates the vascular endothelial growth inhibitor-mediated cell death in human osteosarcoma and vascular endothelial cells
    KOJI YAMANEGI et al, 2015, International Journal of Oncology CrossRef
15. Anti-apoptosis Effect of Decoy Receptor 3 in Cholangiocarcinoma Cell Line TFK-1
    Ying-Chen Xu et al, 2018, Chinese Medical Journal CrossRef
16. DcR3 combined with hematological traits serves as a valuable biomarker for the diagnosis of cancer metastasis
    Junxin Li et al, 2017, Oncotarget CrossRef
17. Co-Expression and Functional Interactions of Death Receptor 3 and E-Selectin in Clear Cell Renal Cell Carcinoma
    Rafia S. Al-Lamki et al, 2022, The American Journal of Pathology CrossRef
18. The paratumoral immune cell signature reveals the potential for the implementation of immunotherapy in esophageal carcinoma patients
    Zuzana Strizova et al, 2020, Journal of Cancer Research and Clinical Oncology CrossRef